WHO approves Thailand's anti-HIV Efavirenz

13 Sept 08:58 Key points summarised by AI

The World Health Organization (WHO) has prequalified Thailand's anti-HIV drug Efavirenz, developed by the Government Pharmaceutical Organization (GPO), making it the first anti-HIV medication from Thailand and the only one from ASEAN to achieve this status.
This WHO certification allows Thailand to market Efavirenz internationally, significantly expanding its reach to countries needing affordable HIV treatment for individuals diagnosed with HIV or suffering from AIDS.
Developed over 16 years, Efavirenz dramatically reduces the cost of anti-HIV medication from 1,800 baht to just 180 baht per bottle, greatly enhancing affordability and accessibility for patients.
The GPO plans to construct a new factory to meet growing international demand, with countries like the Philippines already committing to substantial purchases, and is also seeking WHO endorsement for an anti-HIV cocktail drug.

Sihasak urges Thais in Europe to stay alert as protests spread

Yesterday 12:06 Key points summarised by AI

Thai Foreign Minister Sihasak Phuangketkeow advises Thai nationals in Europe to avoid protest areas and reconsider non-essential travel, citing widespread unrest in countries like France, Italy, and Spain.
The warning comes as demonstrations escalate, with some turning violent, prompting concerns for safety and leading to an emergency Cabinet meeting in Italy and a proposed postponement of diplomatic talks.
Thai embassies and the Department of Consular Affairs issue advisories, urging citizens to monitor local developments, follow official announcements, and register their travel details for assistance, while emphasizing that no Thais have been directly affected yet.